Bistramide A
Severs actin filaments, Covalent sequestration of G-actin of ACTG2
Structure
In Cells
In Model Organisms
SERP ratings and comments
SERP Ratings
SERP Comments:
Portal staff comment: Bistramide A is not a PKC δ activator.
(last updated: 17 Jul 2017 )
SERP Ratings
SERP Comments:
Bistramide A is a novel actin-binding compound that disrupts actin filament formation. The compound has a fairly narrow concentration range and can be used as an orthogonal probe to study actin dynamics.
(last updated: 24 Jul 2017 )
SERP Ratings
SERP Comments:
Bistramide A, at submicromolar concentrations, is shown to bind G-actin and sequester the actin molecule from polymerization into F-actin in cells, but at concentrations higher that 10 uM, the compound starts to inhibit PDBu binding to PKCdelta. So researchers should carefully set an experimental concentration range and should carefully interpret the consequences after treatment of cells with the compound, especially in growth inhibition or toxicity assays, which might yield phenotypes for multiple reasons.
(last updated: 16 Nov 2020 )
SERP Comments:
Bistramide A displays good affinity for actin with Kd=7nM. Its activity in cells is reported in the range of 20mM to 750nM (PMID 3238698 and 7807120) depending on the readout and cancer cell line tested. It is also active in normal human endothelial cells (PMID 3238698). Accordingly, a top probe concentration of 300-500nM might be used in parallel with the recommended concentration of 50-100 nM to cover all bases. This probe was tested in vivo but was reported to be too generally toxic to be able to study its anti-tumor activity (PMID 7807120); its testing in vivo is therefore not recommended.
(last updated: 16 Nov 2020 )